Print Friendly, PDF & Email

NCT/Study#

NCT04720664 /

OASIS

OASIS: Phase II Trial Of Oral SM-88 In Patients With Metastatic Hormone Receptor-Positive HER2-Negative (HR+/HER2-) Breast Cancer.

DISEASE GROUP:
Breast Cancer Clinical Trials
current phase:
Phase II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: